Hedge fund takes stake in Pittsburgh's newest public company
July 12, 2019 at 11:41 AM EDT
Greenlight Capital buying 9 percent of biotech firm's common stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|